Senior Director, Global Medical Strategy, Rare Neurology

The Senior Director, Global Medical Strategy, Rare Neurology is a critical contributor and member of the Global Medical Affairs Leadership Team, reporting to the head of Global Medical Affairs. Maintains key accountability for all GMA roles dedicated to Rare Neurology/ALS including medical strategy and field medical. Will lead launch preparation in a rare disease space, where urgency is required. Works cross-functionally with both US and global counterparts in commercial, market access, payer value, early development, clinical development and others to create and execute strategic asset plans. Leads the strategic generation of scientific data and the consistent and accurate scientific communication about Otsuka’s rare neurology/ALS products in the US and globally.

If you have passion for helping patients in difficult to treat rare and ultra rare conditions and love the excitement of launching a new medicine, we would like to speak to you about this exciting opportunity.

Job Description

• Drive launch strategy and launch preparation activities for all medical affairs deliverables
• Oversees global medical affairs planning and activities in cross-functional collaboration with other US and global functions, while working closely with medical excellence and operations
• Develop and drive the strategic vision for assigned asset (s), as well as contribute to the TrPP (target reimbursable product profile)
• Responsible for annual data gap analysis to develop and evolve the product data generation plan for rare neurology/ALS asset through its lifecycle
• Responsible for the global evidence generation review process to harmonize the global Phase IIIB and IV programs, including Investigator Sponsored Studies and non-interventional studies
• Oversee core content development, in collaboration with the communication strategy lead
• Oversees communication strategy plans inborn error of metabolism asset in collaboration with the communication strategy lead, incl